Capstone Investment Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Buy |
60,620
+620
| +1% | +$184K | 0.03% | 192 |
|
|
2025
Q4 | $16.4M | Sell |
60,000
-1,735
| -3% | -$471K | 0.03% | 197 |
|
|
2025
Q3 | $16.7M | Buy |
61,735
+1,735
| +3% | +$472K | 0.03% | 232 |
|
|
2025
Q2 | $16.5M | Hold |
60,000
| – | – | 0.04% | 170 |
|
|
2025
Q1 | $15.9M | Buy |
+60,000
| New | +$14.8M | 0.04% | 214 |
|
|
2024
Q4 | – | Sell |
-6,205
| Closed | -$1.43M | – | 1872 |
|
|
2024
Q3 | $1.37M | Sell |
6,205
-11,352
| -65% | -$2.35M | ﹤0.01% | 862 |
|
|
2024
Q2 | $3.45M | Buy |
17,557
+10,688
| +156% | +$2.21M | 0.01% | 560 |
|
|
2024
Q1 | $1.48M | Buy |
6,869
+3,940
| +135% | +$828K | 0.01% | 929 |
|
|
2023
Q4 | $617K | Buy |
2,929
+1,921
| +191% | +$410K | ﹤0.01% | 1242 |
|
|
2023
Q3 | $202K | Buy |
+1,008
| New | +$200K | ﹤0.01% | 1808 |
|
|
2023
Q1 | – | Sell |
-10,696
| Closed | -$1.93M | – | 1574 |
|
|
2022
Q4 | $1.8M | Sell |
10,696
-14,091
| -57% | -$2.45M | 0.01% | 743 |
|
|
2022
Q3 | $4.39M | Buy |
+24,787
| New | +$4.9M | 0.03% | 444 |
|
|
2022
Q2 | – | Sell |
-33,555
| Closed | -$7.11M | – | 1871 |
|
|
2022
Q1 | $7.98M | Buy |
+33,555
| New | +$7.88M | 0.02% | 539 |
|
|
2021
Q4 | – | Sell |
-51,858
| Closed | -$11.4M | – | 1874 |
|
|
2021
Q3 | $10M | Buy |
+51,858
| New | +$10.5M | 0.02% | 620 |
|
|
2021
Q1 | – | Sell |
-44,047
| Closed | -$8.68M | – | 1706 |
|
|
2020
Q4 | $8.02M | Sell |
44,047
-27,392
| -38% | -$4.66M | 0.03% | 456 |
|
|
2020
Q3 | $12M | Buy |
71,439
+14,895
| +26% | +$2.51M | 0.06% | 269 |
|
|
2020
Q2 | $9.19M | Buy |
56,544
+51,716
| +1,071% | +$9.27M | 0.06% | 283 |
|
|
2020
Q1 | $835K | Sell |
4,828
-11,540
| -71% | -$2.3M | 0.01% | 764 |
|
|
2019
Q4 | $3.29M | Buy |
+16,368
| New | +$3.36M | 0.02% | 691 |
|
|
2019
Q3 | – | Sell |
-778
| Closed | -$163K | – | 1358 |
|
|
2019
Q2 | $151K | Sell |
778
-12,705
| -94% | -$2.34M | ﹤0.01% | 1289 |
|
|
2019
Q1 | $2.22M | Buy |
+13,483
| New | +$2.38M | 0.02% | 566 |
|
|
2018
Q4 | – | Sell |
-7,978
| Closed | -$1.47M | – | 1252 |
|
|
2018
Q3 | $1.36M | Buy |
7,978
+3,368
| +73% | +$567K | 0.02% | 518 |
|
|
2018
Q2 | $756K | Buy |
+4,610
| New | +$753K | 0.01% | 431 |
|
|
2017
Q2 | – | Sell |
-3,000
| Closed | -$356K | – | 670 |
|
|
2017
Q1 | $356K | Buy |
+3,000
| New | +$361K | 0.01% | 668 |
|
|
2016
Q2 | – | Sell |
-40,220
| Closed | -$3.86M | – | 703 |
|
|
2016
Q1 | $3.86M | Buy |
+40,220
| New | +$3.66M | 0.12% | 121 |
|
Other funds holding CME
VCM
VPM
Capstone Investment Advisors's CME Position: Q1 2026 in Review
Capstone Investment Advisors increased its CME Group (CME) stake by 1% in Q1 2026, buying an estimated $184K and bringing the position to 60,620 shares worth $17.9M. The position accounts for 0.03% of the portfolio, ranked #192.
Capstone Investment Advisors first reported a position in CME in Q1 2016 and has held it in 25 quarters since. 1,796 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Capstone Investment Advisors held 60,620 shares of CME Group worth $17.9M as of Q1 2026.
- Capstone Investment Advisors bought 620 CME Group shares in Q1 2026, an estimated $184K.
- CME Group made up 0.03% of Capstone Investment Advisors's portfolio in Q1 2026, its #192 holding.
- Capstone Investment Advisors first reported a position in CME Group in Q1 2016 and has held it in 25 quarters since.
- 1,796 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.